TP53 and esophageal squamous cell carcinoma: In the study of Hagi et al., molecular barcode sequencing of the TP53 gene enabled comprehensive and highly sensitive detection of ctDNA in patients with ESCC, prior to resection and neoadjuvant therapy as well as after therapy (68).